Health Economics

Health economics evidence can make or break a product. A complete lack of it will almost invariably result in denial of “listing“ or “reimbursement“ by either public or private third-party payors around the world.

While terms like “cost-effectiveness“ or “value for money“ have been floating around for many years now, different jurisdictions understand very different concepts by them.

Our project team is supported by Prof. Dr. York F. Zoellner, an international Key Opinion Leader on health economical thought leadership and consulting.